Abstract
Lupus nephritis is a major cause of mortality and morbidity in patients with systemic lupus erythematosus (SLE). Early diagnosis and treatment are important, as early response to therapy is correlated with better prognosis and quality of life. Here, we report a case of 24-year-old male with SLE along with lupus nephritis. The patient was given 3 cycles of rituximab 1 gm 6 months apart following which the patient went into remission. Thus, Rituximab has been found to be an effective therapeutic modality to induce remission in SLE with Lupus Nephritis and also avoids the potential toxicity associated with standard immunosuppressive agents. Nail fold capillaroscopy (NFC) and trichoscopy were done which helped in the diagnosis of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
